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Abstract
Background: An association between HPV infection and progression to anal squamous intraepithelial lesions (ASIL)
has been established, specifically in high-risk populations such as HIV-infected men. In this population, anal cancer
is one of the most common non-AIDS-defining malignancies.
Methods: A cross-sectional study to detect anal lesions and HPV infection was performed. Anal mucosa samples
were collected from 56 HIV-infected men from Cuba. The cytological diagnosis was done according to Bethesda
2001 System. HPV DNA detection was determined by qPCR for six high-risk HPV types and end point PCR for low-risk
HPV types (6 and 11). The end point PCR with nucleotide sequencing technique was achieved to detect other
genotypes of HPV not included in the qPCR in those samples negative for HPV- 6 and 11 or negative for the six
genotypes identified in the qPCR.
Results: Cytological diagnosis identified 53 of 56 (95%) men with abnormal anal cytology. Among those, 26% (14/53)
had atypical squamous cells of undetermined significance (ASC-US), 4% (2/53) had atypical squamous cells of
undetermined significance cannot exclude high-grade lesions (ASC-H), 64% (34/53) had low-grade squamous
intraepithelial lesions (LSIL), and 6% (3/53) had high-grade squamous intraepithelial lesions (HSIL). HPV DNA
was detected in 89% (50/56) of men and 79% had at least one of the high-risk HPV types. HPV- 16 was the
most common genotype (52%), while HPV-18 was the most frequently detected genotype in men with HSIL.
We found statistically significant differences in the HPV viral loads with respect to the cytology results (p = 0.
0006) and that the practice of receptive anal sex was a risk factor for anal HPV infection (p = 0.032).
Conclusion: This study shows a high prevalence of ASIL and high-risk HPV infections in the study group and
is the first study showing the distribution of HPV genotypes in HIV infected Cuban men with abnormal anal
cytology. This information may be of importance for local decision makers to improve prevention strategies,
including the introduction of HPV vaccine in Cuba.
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Background
While anal carcinoma is rare in the general population
[1], it is one of the most common non-AIDS-defining
malignancies in the era of combination antiretroviral
therapy [2]. It is more frequent among individuals with
human immunodeficiency virus (HIV) infection, particu-
larly in men who have sex with men (MSM) [3]. In the past
decades, the incidence of anal cancer has been increasing
in both general MSM and HIV-infected MSM [4]. The
Cuban AIDS epidemic has a predominance of male HIV-
infected individuals (81%), of which 89% are MSM [5].
Persistent human papillomavirus (HPV) infection, es-
pecially high-risk HPV (HR-HPV) viral types such as
HPV- 16 and HPV- 18, is associated with anal cancer
and its precursor lesions, high-grade anal squamous
intraepithelial lesions (HSIL) [6]. Recent studies have
demonstrated that more than 90% of HIV-positive MSM
were also infected with HPV [2, 7]. This particular group
has a very high risk of developing ASIL and anal cancer
[8]. The development of anal squamous intraepithelial
lesions (ASIL) is associated with HPV infection, as well
as other risk factors such as receptive anal intercourse,
history of sexually transmitted diseases, number of life-
time sexual partners, HIV status, lower CD4 cell count,
and current cigarette smoking [9]. Screening of anal
precancerous lesions in HIV-infected MSM has been
suggested to be important for cancer prevention [10].
Little is known about anal HPV infection or anal cyto-
logical abnormalities in HIV-infected men in Cuba. The
objective of this study was to investigate the distribution
of HPV genotypes, and anal cytological abnormalities in
HIV-infected men in Havana, Cuba.
Methods
Study design and population
We performed a cross-sectional study to detect ASIL
and HPV infection. Study participants were outpatients
of the sexually transmitted diseases (STD) clinic at the
Institute of Tropical Medicine “Pedro Kourí” and were
recruited between April and August 2012. Those eligible
to participate were HIV-positive males with a history of
a previous or current STD, willing to give informed con-
sent to an interview and tests for anal HPV infection
and anal cytology. The inclusion criteria also included
having an anal cytology useful for diagnosis.
Cytological analysis and HPV genotyping
Prior to the sample collection, the anal canal was cleaned
carefully twice using a saline- moistened cotton-flocked
swab. The cytology specimens were collected by mean of
a pre-scored brush (QIAGEN, Hielden, Germany), placed
on a glass slide, stained with a Papanicolaou stain and
classified using the Bethesda system criteria for evaluation
of cervical cytological results [11, 12].
After the cytology, another sample was collected for
DNA extraction. The brush was then placed in a 1 mL
Specimen Transport MediumTM (QIAGEN, Hielden,
Germany). DNA was obtained using the QIAmp DNA
Mini kit (QIAGEN, Germany) following the manufac-
turer’s protocol.
HPV DNA detection was determined by real time
polymerase chain reaction (qPCR) for six HR- HPV types
(HPV −16, −18, −31, −33, −45 and −58), as described
below. HPV- 6 and 11 were detected using type specific
end point PCR with L1 primers [13]. The end point PCR
with nucleotide sequencing technique was achieved to
detect other genotypes of HPV not included in the qPCR
in those samples negative for HPV- 6 and 11 or negative
for the six genotypes identified in the qPCR.
Real time polymerase chain reaction
The methodology used in this study is based on a protocol
previously published by Schmitz et al. in 2009 [14] and it
has already been described in detail in a previous article
by our group [15].
PCR primers and corresponding TaqMan probes were
used for HPV types −16, −18, −31, −33, −45, and −58
for target amplification of the LCR/E6/E7 regions of
HPV genome. To identify and quantify viral load of
those HR-HPV types, single PCR reactions were per-
formed for each HPV type. To control for DNA quality,
β-globin was amplified for each sample, in one of the
reactions. Sequences of primers and probes are listed
below (Table 1).
HPV-16 and 18 standard curves were obtained from
purified genomic DNA of SiHa and HeLa cell lines,
respectively. HPV16-positive cervical carcinoma cell line
SiHa (2 genome copies of HPV-16) and the HPV18-
positive cell line HeLa (10–50 genome copies of HPV-18)
were used to generate standard DNA for measurements of
viral load (tenfold genome dilutions between 106 and 10
copies/μL).
The pattern curves were constructed on the basis of
each of the resulting standard DNA, which showed good
linear correlation (r: 0, 99) and low error values through-
out 6 target DNA concentrations. The system had a
lower detection limit of 10 copies for HPV-16 and other
genetically related genotypes such as HPV- 31, −33 and
−58. The lower detection limit for HPV-18 and other
genetically related genotype, HPV-45, was also of 10
copies of viral genome. No cross reactions between HPV
types and other DNA viruses were observed [14, 16].
PCR was performed in a Light Cycler 1.5 platform
(Roche Molecular Biochemical of Indianapolis, USA).
The PCR reaction comprises 5 μL of DNA (up to 50 ng),
4 μL of Quantitative PCR TaqMan Master Mix (Roche
Molecular Biochemical of Indianapolis, USA), 10 pmol
of each primer and 1 to 5 pmol of each probe in a final
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volume of 25 μL. The initial denaturation step at 94 °C
for 10 min was followed by 45 PCR cycles at 94 °C for
15 s, 50 °C for 20 s and 60 °C for 40 s each.
HPV viral load was measured using absolute quantifi-
cation. The viral load values were expressed as copies/
μL. Cases with more than one HPV type were reported
as multiple infections.
End point PCR and sequencing
The amplification reactions included a set of degenerated
primers MY09/MY11 [17]. Each amplification reaction
was performed in a total volume of 50 μL. The reaction
mixture contained nuclease-free water, 10 mM Tris–HCl
(pH 8.3), 50 mM KCl, 6 mM MgCl2, 200 μM of each
dNTP, 5 μM of MY primers, 2,5-U Taq Polymerase
(Roche, Diagnostics, Indianapolis, USA), and 100 ng of
each DNA. Each PCR was performed with first denatur-
ation step at 95 °C for 10 min, followed by 45 PCR cycles
at 95 °C for 1 min, 55 °C for 1 min and 72 °C for 1 min. A
final extension at 72 °C for 10 min was included.
Polymerase chain reaction products of positive sam-
ples were purified using QIAquick® PCR purification kit
(QIAGEN, Hilden, Alemania). These were subsequently
sequenced using 1 μL of 5 μM of MY09 and MY11 as
the sequencing primers, 8 μL of sequence reaction mix-
ture DTCS Quick Star Master Mix supplied with the
Dye Terminator Cycle Sequencing (DTCS) Quick Start
Kit (Beckman Coulter, Fullerton, CA), 5 μL of purified
DNA and 6 μL of water to complete 20 μL of reaction
mixture. The sequencing reaction consisted of 2 min de-
naturation at 96 °C, followed by 50 cycles of denaturing
at 96 °C for 20 s, 20 s of hybridization at 50 °C, and
4 min of extension at 60 °C. Once the sequence reaction
was concluded, it was purified, after the protocol de-
scribed in the DTCS Quick Star Master Mix commercial
kit (Beckman Coulter). The sequencing fragments were
run on the genetic analysis system CEQ 8800 (Beckman
Coulter). Finally, the sequences were edited and assembled
using Sequencher, version 4.10 (Gene Codes Corporation,
Ann Arbor, MI). Human papillomavirus genotype was
determined using Basic Local Alignment Search Tool
(BLAST, www//ncbi.nih.gov) and confirmed by manual
phylogenetic analysis, using CLUSTAL-X and the
neighbor-joining method in MEGA version 5 (Kimura’s 2-
parameter correction, bootstrap 1000) [18].
Statistical analysis
Data were processed using IBM SPSS Statistics 19. Odds
ratios (ORs) and 95% confidence intervals (CIs) were
calculated, using univariate logistic regression, as esti-
mates of the association of HPV infection and anal
cytology results with potential risk factors. Comparisons
between viral loads from groups of patients with different
cytological classifications were made using the Kruskall-
Wallis and Mann—Whitney tests. All statistical tests were
considered to be significant at a p value of < .05.
Results
A total of 56 eligible participants consented to be included
into this study. The socio-demographic, epidemiological,
and clinical characteristics of the participants are shown
in Table 2. The median age of the participants was 35 years
(range, 20–61 years). The majority of individuals (89%) de-
scribed themselves as MSM, and 66% of these had their
first intercourse at 15 years old or later. Around 84% of
the participants have STD other than HIV at the time of
this study, and 44 (79%) were diagnosed for anogenital
condyloma. Thirty (54%) participants had a recent CD4
cell count between 200 to 500 cells/mL of blood, and 79%
participants ever had highly active antiretroviral therapy
(HAART). About 34% of the participants reported ≥5 anal
sex partners during the last two years.
Overall, HPV DNA was detected in 89% (50/56) men
and 79% (44/56) had at least one of the six HR-HPV




HPV 16 + 5′ gaa ccg aaa ccg gtt agt ata a 3′
HPV 16 - 5′ atg tat agt tgt ttg cag ctc tgt 3′
HPV 16 Probe 5′ cat ttt atg cac caa aag aga act
gca atg ttt c 3′
HPV 18 + 5′ gga ccg aaa acg gtg tat ata a 3′
HPV 18 - 5′ cag tga agt gtt cag ttc ggt 3′
HPV 18 Probe 5′ atg tga gaa aca cac cac aat act
atg gcg cg 3′
HPV 31 + 5′ gaa ccg aaa acg gtt ggt ata ta 3′
HPV 31 - 5′ atc gta ggg tat ttc caa tgc 3′
HPV 31 Probe 5′ cat agt att ttg tgc aaa cct aca gac
gcc atg t 3′
HPV 33 + 5′ gca tga ttt gtg cca agc at 3′
HPV 33 - 5′ ctc aga tcg ttg caa agg ttt 3′
HPV 33 Probe 5′ act ata cac aac att gaa cta cag
tgc gtg gaa tgc 3′
HPV 45 + 5′ cag tgt aat aca tgt tgt gac cag 3′
HPV 45 - 5′ aca gga tct aat tca ttc tga ggt 3′
HPV 45 Probe 5′ caa gaa aga ctt cgc aga cgt agg
gaa aca c 3′
HPV 58 + 5′ cac gga cat tgc atg att tgt 3′
HPV 58 - 5′ tca gat cgc tgc aaa gtc ttt 3′
HPV 58 Probe 5′ ttt caa ttc gat ttc atg cac 3′
β globin + 5′ aca caa ctg tgt tca cta gc 3′
β globin - 5′ caa ctt cat cca cgt tca cc 3′
β globin Probe 5′ tca aac aga cac cat ggt gca tct
gac tcc 3′
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Table 2 Relationship between anal HPV infection and socio-demographic, epidemiologic and clinical risk factors in the studied population




p value OR (CI 95%)







20–29 22 (39) 20 (40) 2 (33) 2.50 (0.30–20.92)
30–39 11 (20) 11 (22) 0 (0) —
40–49 13 (23) 11 (22) 2 (33) 1.38 (0.16–11.94)




15 (27) 14 (28) 1 (17) 2.55 (0.20–31.86)
High School 28 (50) 25 (50) 3 (50) 1.52 (0.22–10.38)
University 13 (23) 11 (22) 2 (33) 1 (Reference)
Marriage status 0.999
Married 9 (16) 8 (16) 1 (17) 1 (Reference)
Unmarried 43 (77) 38 (76) 5 (83) 0.95 (0.10–9.27)




MSM 50 (89) 46 (92) 4 (67) 5.75 (0.79–41.69)
Heterosexual 6 (11) 4 (8) 2 (33) 1 (Reference)
Alcohol consumption 0.196
Yes 23 (41) 19 (38) 4 (67) 0.31 (0.05–1.84)
No 33 (59) 31(62) 2 (33) 1 (Reference)
Smoking 0.229
Yes 24 (43) 20 (40) 4 (67) 0.33 (0.6–2.00)
No 32 (57) 30 (60) 2 (33) 1 (Reference)
CD4+ T cells count 0.465
<200 17 (30) 16 (32) 1 (17) 4.57 (0.35–59.11)
200–500 30 (54) 27 (54) 3 (50) 2.57 (0.36–18.49)
>500 9 (16) 7 (14) 2 (33) 1 (Reference)
Age of first sexual
intercourse (years)
0.362
<15 19 (34) 18 (36) 1 (17) 2.81 (0.30–25.98)
≥15 37 (66) 32 (64) 5 (83) 1 (Reference)
Sexual practice 0.492
Genital 5 (9) 4 (8) 1 (17) 1 (Reference)
Oral/Genital 51 (91) 46 (92) 5 (83) 2.30 (0.21–24.80)
Anal receptive sex 0.032
Yes 47 (84) 45 (90) 3 (50) 9.00 (2.42–57.12)





1 19 (34) 16 (32) 3 (50) 1 (Reference)
2–4 18 (32) 17 (34) 1 (17) 3.19 (0.30–33.89)
5–10 8 (14) 8 (16) 0 —
>10 11 (20) 9 (18) 2 (33) 0.84 (0.12–6.03)
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types that we sought. The most common types detected
were HPV-16 (52%), HPV-11 (48%), HPV-6 (41%) and
HPV-18 (30%). Infection with multiple HPV types was
detected in 71% of the participants (40/56), (Table 3).
We also fund two cases positive for HPV- 53 (possibly
carcinogenic genotype) and HPV-83 (genotype of un-
known carcinogenicity), through generic PCR and DNA
sequencing.
Concerning cytological findings, 53 of 56 (95%) men
had abnormal anal cytology. Among those with abnor-
mal cytology, 26% (14/53) had ASC-US, 4% (2/53) had
atypical ASC-H, 64% (34/53) had LSIL and 6% (3/53)
HSIL.
HPV prevalence was remarkable high in both normal
and abnormal anal cytology. All cases with normal anal
cytology had HPV infection (3/3). Among those with ab-
normal anal cytology, 89% (47/53) were positive for at
least one of HPV type and 74% (39/53) were infected
with multiple HPV types. Among the HPV-positive cases
with abnormal anal cytology, 87% (41/47) had at least
one HR-HPV genotype and 55% (26/47) had more than
two HR-HPV types. The most prevalent HR-HPV types
among cases with abnormal cytology were HPV-16
(51%, 27/53) and HPV-18 (28%, 15/53). HPV-16 was the
major genotype in men with ASC-US, LSIL or ASC-H,
followed by HPV- 33 in men with ASC-US, HPV-18 and
33 in men with LSIL and HPV-18 and 45 in ASC-H.
HPV-18 was the most frequently detected genotype in
men with HSIL, followed by HPV-16 and 58. In men
with normal cytology, HPV-16 and 58 were the most
prevalent types detected, (Table 3).
Viral load analysis was detected for different anal cyto-
logical classifications. HPV viral load levels were signifi-
cantly different among those with different anal cytology
results (p = 0.0006). Those classified as negative and
ASC-US showed lower viral load (median: 8.5×103 copy/
μL, ranges 3.2x102 to 4.6x106 copy/μL and median:
3.7×102 copy/μL, ranges 9.4×101 to 5.1×105 copy/μL, re-
spectively). In contrast, higher viral load was detected in
cases with LSIL, ASC-H and HSIL (median: 6.8×105
copy/μL, ranges 2.1×102 to 1.6×108 copy/μL, median:
3.8×107 copy/μL, ranges 1.1×106 to 2.0×108 copy/μL and
median: 8.5×105 copy/μL, ranges 3.8×102 to 1.4×107
copy/μL, respectively) (Fig. 1).
Table 2 shows the association between HPV infection
and socio-demographic, epidemiological, and clinical
variables analyzed in the studied population. The partici-
pants who had receptive anal sex as a regular sexual
behavior were at higher risk to HPV infection (p = 0.032;
OR = 9.00 CI 95% 2.42-57.12). Sexually transmitted dis-
eases were also a risk factor for viral infection (p = 0.031;
OR = 7.33 CI 95% 1.20-44.96). Regarding HPV infection,
according to age distribution, viral infection was not
associated with age but a slight pick in prevalence for
the 20- to 29-years old individuals was observed.
Table 2 Relationship between anal HPV infection and socio-demographic, epidemiologic and clinical risk factors in the studied population
(Continued)
HAART 0.459
Yes 44 (79) 40 (80) 4 (67) 1 (Reference)
No 12 (21) 10 (20) 2 (33) 0.50 (0.08–3.13)
STD at the time of the study
(except HIV)
0.031
Yes 47 (84) 44 (88) 3 (50) 7.33 (1.20–44.96)
No 9 (16) 6 (12) 3 (50) 1 (Reference)
History of STD (except HIV) 0.690
Yes 43 (77) 38 (76) 5 (83) 0.63 (0.07–5.97)
No 13 (23) 12 (24) 1 (17) 1 (Reference)
The values with statistical significance appear in italic letters
HPV Human papillomavirus, OR Odd ratio, IQR Inter-quartile ratio, CI Confidence interval, MSM Men who have sex with men STD Sexually transmitted diseases, HIV
Human immunodeficiency virus, HAART High activity anti-retroviral therapy
Table 3 HPV types distribution in HIV positive men according
to anal cytology classification



















HR-HPV types 3 (100) 9 (64) 27 (79) 2 (100) 3 (100) 44 (79)
HPV-16 2 (67) 6 (43) 17 (50) 2 (100) 2 (67) 29 (52)
HPV-18 1 (33) 1 (7) 11 (32) 1 (50) 3 (100) 17 (30)
HPV-31 0 1 (7) 5 (15) 0 1 (33) 7 (12)
HPV-33 1 (33) 3 (21) 11 (32) 0 0 15 (27)
HPV-45 1 (33) 2 (14) 5 (15) 1 (50) 0 9 (16)
HPV-58 2 (67) 0 8 (24) 0 2 (67) 12 (21)
HPV 16–18 only 1 (33) 0 4 (12) 0 1 (33) 6 (11)
HPV 16–18 and
other HR-HPV
1 (33) 0 7 (21) 1 (50) 2 (67) 11 (20)
Multiple
infections
3 (100) 7 (50) 26 (76) 1 (50) 3 (100) 40 (71)
HR-HPV types (16, 18, 31, 33, 45 and 58)
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The population with ASIL/ASC-H was compared
with those with normal anal cytology and ASC-US. A
higher prevalence of ASIL/ASC-H was observed among
those having oral/genital sex as a regular sexual behavior
(p = 0.026; OR = 11.69 CI 95% 1.20-114.31). In addition, a
positive diagnosis of STD, predominantly anal condyloma,
was found to be related with an increased risk of ASIL/
ASC-H (p = 0.017; OR = 6.55 CI 95% 1.40-30.58).
Discussion
In the past decade, multiple studies have reported that
anal HPV infection is common among HIV infected men
[19–21]. In Cuba, there are few data about HPV preva-
lence in HIV-infected men [22]. In the present study a
very high prevalence of HPV infection was found in both,
individuals with abnormal and normal anal cytology. This
high prevalence had been also found in various studies
developed in HIV-infected men [7, 8, 23]. Torres et al.
found a global HPV prevalence of 95.8% (95% CI, 94.6 to
96.7). They also found that patients with abnormal cy-
tology presented a higher prevalence of any HPV type
(99.7%), than those with negative cytology results. How-
ever, patients with negative results also had a very high
prevalence of any HPV type (94.1%) [7]. Sahasrabuddhe et
al. detected that the prevalence of any HPV genotype was
94.4% (95% CI, 91.4%–96.6%), and the prevalence of any
carcinogenic HPV genotype was 75.4% (95% CI, 70.5%–
79.9%). They found anal HPV infection in 98.4% of pa-
tients with HSIL and in 89.2% of men with nondysplastic
biopsy findings [8]. These high prevalence rates could be
explained by the effect of chronic HIV infection on nor-
mal immune function, which increases susceptibility to
HPV infection and retention [24]. The mechanisms that
facilitate this are still unknown.
The most common types detected were HPV-16,
HPV-11, HPV-6, and HPV-18, which are included in the
currently used tetravalent HPV vaccine. HR-HPV types
were frequently detected for both, individuals with ab-
normal and normal anal cytology. These results are simi-
lar to studies from different geographic areas [7, 23].
However, Colon-Lopez et al. detected mostly HPV-58,
31 and 51 in high-risk men attending a sexually trans-
mitted infection clinic in Puerto Rico [25]. The differ-
ent prevalence and distribution of anal HPV subtypes
in different study populations is of interest since it
might reflect different geographic distributions of HPV
genotypes or heterogeneous host susceptibility to the
pathogens.
Our cytology results show that the prevalence of
abnormal anal cytology overall was remarkably high,
primarily with LSIL. Only 5.4% (3/56) of the participants
had normal anal cytology.
It is difficult to directly compare the results from dif-
ferent studies due to the various characteristics of the
study participants including age, stage of disease, status
of immune system, and history of HAART. Salit and col-
leges, in 2010, evaluated the prevalence of abnormal anal
cytology based on a cross-sectional study of 401 HIV-
positive MSM from Canada. They found the highest
prevalence of LSIL (43%). In a study of 247 HIV-
Infected MSM, Pokomandy et al. found a prevalence of
abnormal anal cytology of 80.9% [26]. In the present
study, the prevalence of abnormal anal cytology was
higher. According to these figures, further investigations
Fig. 1 Comparison of the medians of HPV viral load among each anal cytology classification. Abbreviations: ASC-US: atypical squamous cells of
undetermined significance, ASC-H: atypical squamous cells of undetermined significance cannot exclude high-grade lesions, LSIL: low-grade
squamous intraepithelial lesions, HSIL: high-grade squamous intraepithelial lesions, NILM: negative for intraepithelial lesion and malignancy
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are needed to confirm the high prevalence of cytological
anal abnormalities in Cuban HIV positive men.
Our results showed receptive anal sex and other STD,
specifically anal warts as risk factors for HPV infection
in the studied population. A past history of receptive
anal intercourse and recent receptive anal intercourses
are the most consistently reported risk factors for preva-
lent anal HPV infections [27]. A recent history of anal
warts and others STD have been described as important
risk factors associated with the prevalence of anal HPV
infections and anal cancer precursor lesions [21, 28].
Among MSM, there are few data on age-specific HPV
prevalence. In our study HPV detection was very high
and viral infection was not associated with age. However,
we observed a slightly high prevalence of anal HPV in
men aged 20- to 29- years.
The majority of studies found a high prevalence of
anal HPV that did not decline with age [29]. Contrary,
in a study by Gao et al. of 578 MSM (528 HIV-negative
and 50 HIV-positive) recruited from two cities in China,
a decrease in anal HPV prevalence was observed with
increasing age (71% for ≤ 19 years, 62% for 20–29 years,
64% for 30–39 years and 54% for ≥ 40 years); however,
this was not statistically significant [30]. In another study
by Nyitray et al. of 179 HIV-negative MSM recruited
through advertisements and from a genitourinary clinic
in three sites in Brazil, Mexico and the US, a signifi-
cantly decreasing age-specific prevalence of anal HPV
was observed, with the highest HPV rates reported in
the 18- to 24-year-old age group. These age-specific
HPV infection prevalence trends may result from age-
specific sexual behavior [31]. Difference source popula-
tions may explain the different age-specific estimates [29].
The significance of the high incidence of HPV detection
in this population is uncertain. One potential explanation
for the high prevalence of anal HPV infection among
MSM and the lack of association with age is that HPV in-
fection in the anus is more persistent than in the cervix.
However, the persistence of some HPV types may not
reflect the true persistence but rather clearance of an HPV
type followed by subsequent exposure or reinfection with
the same type [29].
In our study, higher levels of HPV viral load were
associated with abnormal anal cytology. Tamalet et al.
reported that HPV 16 viral load was an independent fac-
tor for abnormal anal cytology [32]. Rodel and col-
leagues found that HPV 16 DNA load and p16 (INK4a)
expression were significant prognostic factors for local
tumor control and overall survival of patients with anal
cancer following chemo-radiotherapy [33]. However,
Poizot-Martin et al. found that there was not associ-
ation between HPV 16/18 viral loads and abnormal
anoscopic results [34]. Longitudinal studies are needed
to evaluate the link between high anal HPV DNA load
and progression to anal squamous intraepithelial le-
sions and anal cancer.
Some limitations of this study should be considered.
The small sample size of this study limited the analysis
when interpreting the prevalence data, mainly to perform
statistical association analysis. On the other hand, even
when anal cytology results were confirmed by biopsy
using standard anoscopy and patients were treated prop-
erly, this study had no access to biopsy results and to the
outcome of each patient, because they were attended at
coloproctology consults from different hospitals.
Conclusion
In this study we found for the first time in Cuba, a high
prevalence of HR-HPV infection in anal mucosa of HIV
infected men. Because a large number of cases have
shown cytological abnormality, we suggest the possibility
of including a screening for HPV detection and genotyp-
ing in anal cancer precursor lesions of HIV seropositive
individuals. This would facilitate the clinical manage-
ment of these patients in the presence of anal cancer
precursor lesions, taking into account the increased inci-
dence of this disease in this risk group. Moreover, the
information reported here may be useful to consider the
possibility of including HPV vaccination in Cuba.
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